Stocktoria
Haleon plc HLN.L
GB · London Stock Exchange · XLON · stock · Healthcare · website
Haleon plc financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $11.0B | $11.2B | $11.3B | $10.9B |
| Gross profit | $7.1B | $6.8B | $6.7B | $6.6B |
| R&D expense | $316.0M | $298.0M | $311.0M | $300.0M |
| SG&A expense | $4.4B | $4.5B | $4.4B | $4.5B |
| Operating income | $2.4B | $2.2B | $2.0B | $1.8B |
| Interest expense | $347.0M | $394.0M | $414.0M | $278.0M |
| Income tax | $472.0M | $435.0M | $517.0M | $499.0M |
| Net income | $1.7B | $1.4B | $1.0B | $1.1B |
| EPS (diluted) | — | $0.16 | $0.11 | $0.12 |
| Operating cash flow | $2.6B | $2.3B | $2.1B | $2.1B |
| Free cash flow | $2.2B | $2.0B | $1.8B | $1.7B |
| Cash & equivalents | $1.3B | $2.2B | $994.0M | $606.0M |
| Inventory | $1.0B | $1.2B | $1.4B | $1.3B |
| Total assets | $32.6B | $34.3B | $34.1B | $34.8B |
| Total liabilities | $16.1B | $18.1B | $17.3B | $18.4B |
| Shareholders' equity | $16.4B | $16.2B | $16.6B | $16.3B |
Growth · year-over-year · Revenue CAGR 0.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -1.8% | -0.6% | +4.1% | — |
| Net income growth | +15.6% | +37.5% | -1.0% | — |
| EPS growth | — | +38.9% | -1.7% | — |
| Free cash flow growth | +12.0% | +12.4% | +1.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · GB · as of 2025-12-31. Figures in GBp; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.